Please Wait
Applying Filters...
menu
    • menu
    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    Boai NKY Pharmaceuticals Ltd. is one of the largest global PVP suppliers.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    An Enquiry

    Nanjing Well is focused on R&D, production & sales of Pharmaceutical Excipients & Synthetic Lubricating base oils.

    Virtual Booth

    Contact Supplier

    Ever Pharma, highly specialized CDMO in producing complex injectables including high potency & controlled substances, suspensions, etc.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    An Enquiry

    Menu

    Oxaliplatin

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Drugmakers Seek NPPA Aid as Platinum Surge Hits Cancer Drug
    Drugmakers Seek NPPA Aid as Platinum Surge Hits Cancer Drug

    11 May 2026

    // PHARMABIZ

    https://www.pharmabiz.com/NewsDetails.aspx?aid=185828&sid=1

    PHARMABIZ
    11 May 2026
    Share Share
    Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge
    Cancer Drug Makers Seek 50% Price Hike Amid Platinum Surge

    06 Apr 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/cancer-drug-makers-seek-50-price-hike-as-platinum-surge-hits-production-viability/articleshow/130046021.cms

    ECONOMICTIMES
    06 Apr 2026
    Share Share
    Regulatory Tracker: Az's Imfinzi Scores EU Label Expansion
    Regulatory Tracker: Az's Imfinzi Scores EU Label Expansion

    16 Mar 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026

    FIERCE PHARMA
    16 Mar 2026
    Share Share
    AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer
    AstraZeneca Wins CDSCO Nod for Durvalumab in Gastric Cancer

    06 Feb 2026

    // ECONOMICTIMES

    https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/astrazeneca-gets-cdsco-approval-for-durvalumab-in-gastric-cancer-treatment/articleshow/127904949.cms

    ECONOMICTIMES
    06 Feb 2026
    Share Share
    FDA Accepts Exelixis' NDA for Zanzalintinib + ICI in Cancer
    FDA Accepts Exelixis' NDA for Zanzalintinib + ICI in Cancer

    02 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260130221586/en/Exelixis-Announces-U.S.-FDA-Accepted-the-New-Drug-Application-for-Zanzalintinib-in-Combination-with-an-Immune-Checkpoint-Inhibitor-for-Patients-with-Metastatic-Colorectal-Cancer

    BUSINESSWIRE
    02 Feb 2026
    Share Share
    Shandong’s Generics Oxaliplatin Receives Approval in US
    Shandong’s Generics Oxaliplatin Receives Approval in US

    14 Jan 2026

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219765

    FDA
    14 Jan 2026
    Share Share
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.